Literature DB >> 3423618

Degradation in vivo of articular cartilage in rheumatoid arthritis and juvenile chronic arthritis by cathepsin G and elastase from polymorphonuclear leukocytes.

M Velvart1, K Fehr.   

Abstract

Peroxidase-anti-peroxidase (PAP) staining and specific antibodies against cathepsin G and elastase from polymorphonuclear leukocytes (PMN) were applied to pannus-free and microscopically intact superficial articular cartilage. Restricted local deposits containing cathepsin G and elastase were found in three of ten patients with seropositive rheumatoid arthritis (RA), in one of three patients with seronegative RA and in one patient with juvenile chronic arthritis (JCA). Similarly, localized deposits of IgG and C3 were found in the patients with seropositive RA and JCA, but not in the patient with seronegative RA. Adjacent sections exhibited esterase activity in and around the PMN. In proteinase-positive areas from patients with seropositive RA the inhibitors alpha 1-proteinase inhibitor (alpha 1-PI) and alpha 2-macroglobulin (alpha 2-MG) were present in two of three and one of three patients, respectively. In JCA only alpha 1-proteinase inhibitor was present, and in seronegative RA no inhibitors were found. No staining of articular cartilage was observed in a patient with psoriatic arthritis. One of three cases with osteoarthritis exhibited patchy superficial staining for IgG only. In articular cartilage covered by pannus, in three patients with seropositive RA, in one with seronegative RA and in the patient with JCA a few regions with variably dense PMN infiltrates were observed. Cathepsin G, elastase and esterase activity were found in and around the PMN. In one of the three patients with seropositive RA the adjacent cartilage-pannus junction exhibited distinct staining for cathepsin G and elastase, but not for IgG/C3 and proteinase inhibitors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3423618     DOI: 10.1007/BF00541377

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  43 in total

1.  Elimination of protease-inhibitor complexes from the arthritic joint.

Authors:  L Ekerot; K Ohlsson; L Necking
Journal:  Int J Tissue React       Date:  1985

2.  The degradation of articular collagen by neutrophil proteinases.

Authors:  P M Starkey; A J Barrett; M C Burleigh
Journal:  Biochim Biophys Acta       Date:  1977-08-11

3.  Human cathepsin G. Catalytic and immunological properties.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1976-05-01       Impact factor: 3.857

4.  Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes.

Authors:  H Burkhardt; M Schwingel; H Menninger; H W Macartney; H Tschesche
Journal:  Arthritis Rheum       Date:  1986-03

5.  Cathepsin G from human polymorphonuclear leukocytes cleaves human IgM.

Authors:  A Baici; M Knöpfel; K Fehr
Journal:  Mol Immunol       Date:  1982-05       Impact factor: 4.407

6.  Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues.

Authors:  O Ohno; T D Cooke
Journal:  Arthritis Rheum       Date:  1978-06

7.  Study of enzyme inhibitors in the rheumatoid pannus-cartilage area.

Authors:  E D Flory; K D Muirden
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

8.  Effect of oxygen-derived free radicals on hyaluronic acid.

Authors:  R A Greenwald; W W Moy
Journal:  Arthritis Rheum       Date:  1980-04

9.  [Immune complexes: mediators for the formation of inflammatory granulation tissue? Immunohistologic studies of the hyaline articular cartilage in chronic polyarthritis].

Authors:  H Menninger; M Lambusch; W Mohr; D Wessinghage
Journal:  Z Rheumatol       Date:  1983 Jan-Feb       Impact factor: 1.372

10.  Interaction of cells with immune complexes: adherence, release of constituents, and tissue injury.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

View more
  17 in total

1.  Granulocyte elastase in cirrhotic patients with spontaneous bacterial peritonitis.

Authors:  F Casafont; M Rivero; M D Fernandez; J Crespo; E Fabrega; E Sánchez; F Pons-Romero
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

2.  Regulation of human neutrophil-mediated cartilage proteoglycan degradation by phosphatidylinositol-3-kinase.

Authors:  C S Hii; L A Marin; D Halliday; D M Roberton; A W Murray; A Ferrante
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

3.  2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

4.  Activation of synovial fibroblasts in rheumatoid arthritis.

Authors:  R W Kinne; E Palombo-Kinne; F Emmrich
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

5.  Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis.

Authors:  Y Okada; N Takeuchi; K Tomita; I Nakanishi; H Nagase
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

6.  Improvement in rheumatoid arthritis following application of an extracorporeal granulotrap column, G-1.

Authors:  J Fujimori; S Yoshino; M Koiwa; H Hirai; H Shiga; N Hayama; Y Iino
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

7.  Link peptide cartilage growth factor is degraded by membrane proteinases.

Authors:  M F Dean; P Sansom
Journal:  Biochem J       Date:  2000-07-15       Impact factor: 3.857

8.  Plasma and synovial fluid levels of granulocytal elastase-alpha-1-protease inhibitor complex in patients with rheumatoid arthritis.

Authors:  K Kuramitsu; A Yoshida
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

9.  Tumor necrosis factor priming of peripheral blood neutrophils from rheumatoid arthritis patients.

Authors:  I C Kowanko; A Ferrante; G Clemente; P P Youssef; M Smith
Journal:  J Clin Immunol       Date:  1996-07       Impact factor: 8.317

10.  Glutaminyl cyclases as novel targets for the treatment of septic arthritis.

Authors:  Annelie Hellvard; Katarzyna Maresz; Stephan Schilling; Sigrid Graubner; Ulrich Heiser; Roland Jonsson; Holger Cynis; Hans-Ulrich Demuth; Jan Potempa; Piotr Mydel
Journal:  J Infect Dis       Date:  2012-11-29       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.